Background: The American Society of Clinical Oncology Annual Meeting is the largest forum for presentation of clinical research in oncology. We quantified the contribution of countries and assessed correlates of their presence at such meetings.
introduction
Cancer research is a multinational endeavor encompassing the work of health professionals from various disciplines, as well as basic and social scientists, statisticians, and others. These individuals usually present their scientific work in abstract form at national and international meetings. The American Society of Clinical Oncology (ASCO) Annual Meeting is considered the largest forum in which oncology professionals from all over the world report the latest advances in clinical cancer research [1] . Only a few attempts have been made to evaluate and compare the scientific output of the various countries and world regions that contribute to cancer research. Most of these studies have focused on European countries [2] [3] [4] ; when other countries and world regions were also analyzed, their scientific output was compared using published studies [2] [3] [4] [5] [6] . Although various authors have reported on the fate of abstracts presented at scientific meetings [7] [8] [9] [10] [11] , including those presented at ASCO Annual Meetings [12] [13] [14] [15] , to our knowledge, no attempt has been made to investigate the geographic distribution of abstracts selected for the ASCO Annual Meetings. We therefore conducted a bibliometric analysis of a random sample of abstracts presented at recent editions of these meetings, in an attempt to quantify the relative contribution of the various countries and world regions represented at ASCO Annual Meetings, as well as to explore differences in the scientific output of different countries.
methods selection of abstracts
The population of interest in this study comprised all abstracts published in the Program Proceedings and Late-breaking-Abstract Booklets of the ASCO Annual Meetings from two 3-year periods separated by an interval of 5 years (2001-2003 and 2006-2008) . We reasoned that the assessment of these two periods could provide enough material for analysis as well as a longitudinal view of possible recent trends regarding the geography of cancer research. Studies accepted by the Program Committee of the ASCO Annual Meeting may be presented in several forms, ranging from plenary and oral sessions to poster sessions. In addition, some studies appear only in the Program Proceedings and are termed publication only. For the current study, we considered the following three categories of presentation: (i) oral, which includes plenary and oral presentations, as well as integrated original article and clinical science symposia; (ii) poster, which includes abstracts presented in poster discussion and in general poster sessions; and (iii) publication only. After stratification for these three categories of presentation, we selected a random sample comprising 10% of the abstracts for each of the 6 years of interest. The selection was done following lists of random digits generated for each of the three categories in each of the 6 years, using a web-based tool (www.random.org). Studies accepted for the ASCO Annual Meeting are classified by the Program Committee according to topics, which may relate to tumor type (e.g. breast cancer), mode of therapy (e.g. developmental therapeutics), and aspects of care (e.g. patient care), and these designations were also used in our analysis. Study phase was one variable of interest and was determined using the same definition used by the authors in the title or main text of the abstracts. When this definition had not been provided, we made no attempt to classify studies according to their phase. Also, in the current paper, we make no attempt to appraise the results or scientific merit of the abstracts. We did not quantify the occurrence of, and did not exclude studies giving origin to, more than one abstract during the period of interest in our analysis.
assessment of the nationality of abstracts
The nationality of abstracts was based on the affiliation of authors (i.e. the institutions listed) in the print version of the Program Proceedings and Late-breaking-Abstract Booklets for the 6 years of interest. Each abstract was assigned one nationality which was straightforward when there was a single institution or when all institutions of a given abstract were from the same country (henceforward termed multicenter, uninational studies). For abstracts representing more than one country, we assigned nationality by the country of the first institution listed when there was equal number of institutions per country. When the number of institutions per country was unequal with respect to at least one country, two situations might arise: either one country had more institutions than all the others or two or more countries had the same number of institutions, regardless of the number of institutions for the other countries listed (provided these latter countries had fewer institutions than the two or more tying countries). When one country had more institutions than all the others, this country was used to assign the abstract nationality, regardless of the country of the first institution listed. If two or more countries had the same number of institutions, we assigned nationality using the country of the institution first listed in the abstract (considering only the tying countries).
statistical analysis
We obtained summary statistics for the variables of interest and calculated proportions and corresponding 95% confidence intervals (CIs) when appropriate. Proportions were compared using the chi-square test. We assessed temporal trends by comparing proportions of abstracts with the characteristics of interest in each of the two 3-year periods. Exploratory analyses were planned before data collection with regard to the relationship between abstract nationality and category of presentation, study phase, and involvement of the pharmaceutical industry. After data collection, we decided to conduct exploratory analyses of nationality by grouping abstracts into USA studies and non-USA studies. Odds ratios (ORs) and logistic regression models were used to investigate potential predictors of categorical outcomes. All reported P values are two sided and statistical significance was considered if P <0.05. Statistical analysis was carried out using MedCalc (version 9.6.0.0; MedCalc Software bvba, Mariakerke, Belgium). Table 1 shows the distribution of such abstracts according to the three categories of presentation, whereas Table 2 displays the distribution of the abstracts according to their topic and other characteristics. In Table 2 , some of the topics were grouped for were from a single institution and 1301 (59%) were multiinstitutional. Among the latter, 969 were multicenter, uninational, and 332 were multinational studies. Table 3 compares the number of abstracts sampled and the corresponding total number of abstracts accepted for the 6 years of interest for each topic. For the majority of topics, the percent of abstracts randomly sampled remained between 9.0% and 11.0% of the eligible population of abstracts, with the largest discrepancies occurring in topics with smaller total number of eligible abstracts.
nationality of abstracts
Overall, 71 countries were represented in the affiliations of authors of the 2206 abstracts. The top 15 abstract nationalities during the 6 years of interest are shown in Figure 1 . Such nationalities accounted for 90% of all abstract nationalities and USA nationality was assigned to 49.0% of abstracts (95% CI 46.9% to 51.1%). The breakdown of the top 12 nationalities according to the multiplicity of countries and institutions appears in Table 4 , which also shows the relative contribution of each nationality within the category. The same nationalities occupy the top four positions in single-institution and in multicenter, uninational studies, whereas only the USA nationality remained in the same position in multinational studies. There was no significant difference in the proportion of abstracts with USA nationality when these two periods were compared (P = 0.315).
recent temporal trends in abstract nationality
categories of presentation Table 5 shows the distribution of categories of presentation according to the origin of studies in terms of multiplicity of institutions and countries. There was a graded increase in oral and poster presentations, accompanied by a decrease in publication-only abstracts, along the continuum of studies from single institutions, those that were multicenter, uninational, and those that were multinational (P < 0.001).
The proportion of phase I/II/III studies presented orally or in posters (65.0%) was higher than that of studies in which the phase was other, unknown, or not applicable (53.4%; P < 0.001). Likewise, studies with declared sponsorship or coauthorship from the pharmaceutical industry (70.8%) were more likely than those without such involvement (53.6%) to be presented in oral or poster fashion (P < 0.001). Finally, studies with USA nationality were more likely to be presented in oral or poster fashion (67.7%) than non-USA studies (46.6%; P < 0.001 
discussion
This bibliometric analysis provides a geographic overview of cancer research presented at ASCO Annual Meetings. Our study indicates that nearly half of all abstracts are from the USA with a few other countries accounting for the vast majority of the remaining one-half. In other words, 20% of countries represented in the Annual Meetings assessed produce nearly 90% of all abstracts accepted for the meetings, an interesting illustration of Pareto's principle used in economics. According to this principle, a small proportion of the participants in a given economic system account for the majority of effects [16] . The chief limitation of our study is the uncertainty regarding the representativeness of the sample analyzed vis-à-vis the whole population of abstracts accepted for the six annual Given our choice to analyze the largest proportion of abstracts (10%) that would make this study feasible, we reasoned that some form of stratification should be used before random selection of the sample. We used the category of presentation as the stratification factor because such categories represent a hierarchy of studies, regarding their quality as judged by the ASCO Annual Meeting Program Committee. It is conceivable that other study features, such as topic and phase, could be used in an attempt to obtain a representative sample of the population of interest. However, stratifying by topic would add much greater complexity to the study due to the number of topics in the Annual Meeting and also because some of the topics have changed or branched out along the years. With regard to study phase, this information is not used for categorization of the abstracts by the Program Committee and, as shown by our study, is not readily available or not applicable in a large percentage of abstracts. Due to the play of chance, the question of representativeness is of greater concern for countries with fewer abstracts accepted for the annual meeting, a theoretical concern that is empirically illustrated in Table 3 , where the largest deviations from the target sampling of 10% occurred in topics with fewer eligible abstracts. For countries with a small number of abstracts, other study approaches should be used in order to assess their participation at these meetings. We have recently used one of these alternative approaches in the case of Brazilian abstracts presented at five consecutive editions of the ASCO Annual Meeting (2001) (2002) (2003) (2004) (2005) [15] . In that case, we attempted to identify every single Brazilian study and showed that 84 of 9763 (0.86%) abstracts from 2001-2003 were from Brazil; in the current study, Brazilian studies comprised 0.71% (95% CI 0.34% to 1.46%) of the abstracts randomly selected from the same 3-year period. The inclusion of the former percentage in the 95% CI of the latter lends further support to the notion that our sample is representative of the whole population of interest.
Another obvious limitation of our analysis is the fact that we had no information on abstracts that were reviewed by the Program Committee and rejected. A full picture of the current state of the geography of clinical cancer research would only be possible if those studies were also taken into account. Also, we only looked at abstracts presented at the ASCO Annual Meeting. Although this meeting is worldwide renowned and probably the most important scientific event in clinical oncology, it is possible that an assessment of studies presented elsewhere would show a different distribution of the geographic origin of cancer research, especially in meetings held in Europe and in Asia. Finally, an assessment of published studies could also show a different picture with regard to the nationality of studies, in comparison with meeting abstracts, given that the rates of full publication of such abstracts may differ significantly between countries.
With regard to category of presentation, the current study indicates that oral and poster presentations were more frequent with USA studies, those from multiple institutions, and in clinical trials, in the latter case considering the statement of study phase in the abstract. On the other hand, involvement by the pharmaceutical industry did not correlate with presentation in oral or poster fashion independently. The latter finding may be considered reassuring, in the sense that abstracts with declared sponsorship or coauthorship by the pharmaceutical industry, although more likely to be presented in oral or poster fashion in univariate analysis, probably owe such presentations to other associated characteristics, such as nationality, multiinstitutionality, and study phase. It should be noted that in the present study we did not attempt to assess the role of other potential predictors of oral or poster presentation, such as study quality and native language of authors.
The results related to pharmaceutical industry involvement should be interpreted with caution. First of all, we were only able to assess declared involvement, which is perhaps a surrogate for real involvement in study design, conduct, analysis, and reporting. It should also be noted that we did not approach this question from the perspective of conflicts of interest, as done recently by other investigators [17] [18] [19] .
Our study also provides insight regarding multinational collaboration in cancer research, with the caveat that we report abstract nationality and not proper geographic origin. For single-institution and uninational studies, which comprise 85% of abstracts, these two notions are identical. For the 15% of multinational studies, however, we assigned nationality through an algorithm developed for this study, and the arbitrary criteria that we used may be subject to criticism. In previous reports, study nationality has been assigned in many cases using the country of the corresponding author of full papers. The agreement between these two systems for assigning nationality is not known. Nevertheless, we believe our criteria have a sound basis and probably reflect the predominant nationality of multinational studies. As shown in Table 4 , some countries appear to have a higher scientific output in collaborative studies, especially those involving other countries.
We believe our results may be summarized as follows. Most studies presented at recent editions of the ASCO Annual Meetings were uninational, although multinational collaboration seems to be increasing. A minority of countries contributing to cancer research produce the vast majority of the scientific output. The USA alone are responsible for nearly half of the work presented at these meetings, with no recent trend in their participation. Finally, the pharmaceutical industry plays an important role in cancer research presented at ASCO Annual Meetings and this role seems more prominent in multinational studies and in those from the USA. Despite the wealth of information generated by our study, many issues remain unanswered in the attempt to increase our understanding of the role played by various countries and world regions in cancer research. Among such issues, the publication rate of abstracts according to nationality, the scientific output of nations according to socioeconomic factors and local cancer epidemiology, and the relationship between abstract nationality and study quality are only a few of the many issues that we consider worthy of future studies.
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